Back

Pembrolizumab as a rare etiology of myocarditis

12 May 2024 (16:09 - 16:18)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 4 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Miguel De La Serna Real De Asua

University Hospital Getafe, Madrid (Spain)

4 More presentations in this session

Presentation thumbnail
Osimertinib-induced heart failure.
Doctor B. Andrade (Santarem, PT)
Slides Video
Presentation thumbnail
Complex cardiovascular manifestations after cancer treatment: a case of severe aortic and mitral stenosis with coronary artery disease
Doctor R. Fernandes (Coimbra, PT)
Slides Video
Presentation thumbnail
Primary cardiac diffuse large B-cell lymphoma: when the cause of heart failure is so massively unexpected
Doctor M. Martinho (Almada, PT)
Slides Video
Presentation thumbnail
A rare case of diffuse large B-cell lymphoma with cardiac involvement
Doctor I. Martins Moreira (Vila Real, PT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 4

The Event

Event poster

Heart Failure 2024

12 May 2024 16:09 CET
You may be interested in
thumbnail
Congress Presentation
When the heart is affected while fighting cancer: immune checkpoint inhibitor–associated myocarditis
thumbnail
Congress Session
Immune checkpoint inhibitors and the heart
thumbnail
Congress Presentation
Pericarditis: disease progression or immune checkpoint inhibitor complication?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources